BIAF — bioAffinity Technologies, Inc.
—
Nasdaq ·
Health Care ·
Life Sciences Tools & Services ·
CIK 1712762 ·
Last close
$0.77
Market Cap
$4.82M
52W High
$3.31
52W Low
$0.73
ADV30
557,434
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 1,351,527 | 422,891 | -3,616,976 | -3,630,610 | 7,945,252 | 3,098,366 | 4,283,866 |
| Dec 2025 | 1,538,813 | 638,687 | -3,190,963 | -3,137,466 | 10,960,772 | 6,449,782 | 3,683,116 |
| Sep 2025 | 1,446,066 | 503,855 | -2,292,846 | -5,051,084 | 11,546,369 | 7,669,195 | 2,644,171 |
| Jun 2025 | 1,269,483 | 252,881 | -2,515,560 | -4,060,787 | 4,751,075 | 802,835 | 6,887,183 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-10,914,307
Investing CF
$-15,445
Financing CF
$13,583,412
CapEx
$-69,877
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-15.45
As of
2026-06-07
Balance + Analyst (yfinance extras)
Retained Earnings
$-68,554,064
Inventory
$53,548
Receivables
$541,962
ST Investments
—
EBIT TTM
$-14,821,340
Pretax Income TTM
$-14,865,712
Interest Exp TTM
$44,372
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$5,659,889
EBITDA
$-11,097,579
Free Cash Flow
$-6,144,603
Enterprise Value
$1,810,286
Total Cash
$3,098,366
Total Debt
$1,382,591
Shares Out
6,283,061
Trailing EPS
$-4.67
Book Value
$0.81
ROE
-622.6%
ROA
-107.1%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 6,107,959 | -10,626,508 | -14,909,754 | 10,960,772 | 3,683,116 | — | -9,328,842 |
| Dec 2024 | 9,362,022 | -8,953,445 | -9,039,831 | 6,513,667 | 3,911,631 | — | -7,264,795 |
| Dec 2023 | 2,532,499 | -7,973,228 | -7,937,011 | 8,221,552 | 3,366,297 | — | -6,037,806 |
| Dec 2022 | 4,803 | -4,011,058 | -8,154,113 | 12,182,125 | 1,138,682 | — | -4,070,845 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.60
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| BMRA | BIOMERICA INC | $5.22M | $1.69 | — |
| BUDZ | WEED, INC. | $4.29M | $0.03 | — |
| CDIO | Cardio Diagnostics Holdings, Inc. | $5.42M | $1.83 | — |
| ISPC | iSpecimen Inc. | $3.59M | $2.50 | — |
| VRAX | Virax Biolabs Group Ltd | $3.25M | $4.08 | — |
News headlines (Yahoo Finance, 1h cache)
BIAF Stock Plunges 77% in 3 Months: Should You Still Hold or Sell?
2026-07-09 17:34 · Yahoo
bioAffinity Technologies’ Quarterly CyPath® Lung Sales Double to New Record as Commercial Momentum Continues
2026-07-07 12:46 · Yahoo
Q2 Virtual Investor Summit Presentations Now Available On Demand
2026-06-30 17:20 · Yahoo
Q2 Investor Summit Virtual Live Wednesday June 24
2026-06-23 19:40 · Yahoo
bioAffinity Technologies Reports Positive Preclinical Findings Showing Proprietary Gene Silencing Technology Is Selectively Cytotoxic to Squamous Skin Cancer Cells Without Harming Healthy Cells
2026-06-22 12:00 · Yahoo
WallachBeth Capital Announces Closing of bioAffinity Technologies $3.2 Million Offering
2026-06-18 18:15 · Yahoo
bioAffinity Technologies Announces Closing of $3.2 Million Offering
2026-06-18 17:16 · Yahoo
WallachBeth Capital Announces Pricing of bioAffinity Technologies $3.2 Million Offering
2026-06-17 14:40 · Yahoo
bioAffinity Technologies Announces Pricing of $3.2 Million Offering
2026-06-17 13:25 · Yahoo
bioAffinity Technologies Announces Program to Advance Veteran Lung Health: Philips, bioAffinity Technologies and 4DMedical Highlight New Approaches to Lung Health Screening for U.S. Veterans
2026-06-16 12:06 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.